Biologic injections Glendale: care made from blood, not a drug

What can calm the soreness at home?

Start gently. Lower the strain on the motion that began the ache, but don’t spend the whole day still; easy bending or a brief walk can keep stiffness from building up. Heat won’t fix the cause, but it can loosen the joint after sleep. Cold won’t fix it either, but may help when activity brings swelling.

Don’t push through a sharp jab. Don’t keep going if you start limping or guarding the joint. Firm shoes won’t heal the joint, but may help with chores. A cane or brace can make walking easier. Your doctor can compare a pain drug with the other medicine you take.

Keep moving without making the soreness worse.

What goes into biologic injections?

Usually, your own blood. The short name is PRP, for platelet-rich plasma. A clinician draws blood from your arm. A machine spins it and separates the platelet-rich part. Platelets are tiny pieces of blood that form clots and carry healing proteins. The hope is that those proteins calm soreness and help tissue work better. The prepared blood then goes into the sore joint or tendon. Concentrated PRP has a larger share of platelets, but more platelets don’t prove you’ll get more relief.

QC Kinetix offers consultations about regenerative treatments; that broad name covers care made from blood, marrow, fat, or donor tissue. You may also hear biologic therapies or natural pain treatments for this body-based care. Joint preservation means trying to keep the joint useful before surgery. None of those terms means the joint will grow back.

Here’s the catch. You can’t count on relief, and it may take time.

When does this need a closer look?

Get it checked when soreness changes your day. You may walk less, wake at night, avoid stairs, or lose reach in your arm. Write down earlier care and bring old X-rays. Show exactly where it hurts before the clinician checks motion and strength.

Don’t wait after sudden weakness, a locked joint, or an injury that stops you from bearing weight. Heat, redness, swelling, and fever need care now. New numbness with lost bladder or bowel control also needs quick help.

When the joint limits daily life, find out why.

Sources

1. The ESSKA-ORBIT European consensus on blood-derived orthobiologics graded 28 question-statement sets; only 9 of 28 had high-level scientific support. Three statements reached grade A: that there is enough preclinical and clinical evidence to support PRP use in knee OA; that clinical evidence shows effectiveness in MILD TO MODERATE knee OA (KL grade 3 or lower); and that PRP provides a longer effect than the short-term effect of corticosteroid with a safer profile. The panel regarded PRP as a valid and possible first-line injectable option for KL grades 1-3.

   Laver L, et al. — The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma).. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12077.

2. The companion ESSKA-ORBIT consensus on cell-based therapy (77 experts, 22 countries, 27 statements) found only 5 of 27 statements reached recommendation level A or B; 22 were rated C or D. It concluded that cell-based therapy shows clinical benefit in pain and function up to 12 months for KL grades 1-3 with some benefit in selected KL 4, but that because of limited high-quality studies and NO clear superiority over other injectables it should be considered a SECOND-LINE option, after other non-operative treatment fails.

   de Girolamo L, et al. — The use of injectable orthobiologics for knee osteoarthritis: A formal ESSKA-ORBIT consensus. Part 2-Cell-based therapy.. Knee Surgery, Sports Traumatology, Arthroscopy, 2025. DOI: 10.1002/ksa.70001.

3. FDA states verbatim of stem cell products, stromal vascular fraction (adipose-derived cells), umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products: 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA (Center for Biologics Evaluation and Research), 2020.

4. The AAOS patient-education FAQ on orthobiologics states that because orthobiologics are relatively new the evidence supporting their use is LIMITED, that rigorous testing of effectiveness in most orthopedic conditions is lacking, and that preliminary results are encouraging but hard to evaluate. It names tendinopathies such as tennis elbow, pain from early knee osteoarthritis, adjunct healing after rotator cuff repair, and avascular necrosis as the settings where biologic therapies have shown promise, and notes that stem cell treatments not derived from the patient's own body and further manipulated in a laboratory can only be offered inside an FDA-approved clinical trial.

   American Academy of Orthopaedic Surgeons — Orthobiologics (Regenerative Medicine) FAQ. OrthoInfo (AAOS), 2024.

5. The AAOS third-edition clinical practice guideline on non-arthroplasty management of knee osteoarthritis contains 29 recommendations and explicitly highlights intra-articular corticosteroid, hyaluronic acid AND platelet-rich plasma as the areas where better research is still needed - including osteoarthritis characterisation, subgroup and severity stratification, control for bias, and cost-effectiveness analysis.

   Brophy RH, Fillingham YA. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.

6. A 2021 JAMA review of hip and knee osteoarthritis places intra-articular steroid injections as providing SHORT-TERM pain relief within a management model whose cornerstones are exercise, weight loss if appropriate and education, complemented by topical or oral NSAIDs, with joint replacement reserved for advanced symptoms and structural damage.

   Katz JN, et al. — Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.. JAMA, 2021. DOI: 10.1001/jama.2020.22171.